ALDER BIOPHARMACEUTICALS INC's ticker is and the CUSIP is 14339105. A total of 5 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 5.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $4,000 | +33.3% | 125 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $3,000 | 0.0% | 125 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $3,000 | -25.0% | 125 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $4,000 | 0.0% | 125 | 0.0% | 0.00% | -33.3% |
| Q3 2015 | $4,000 | -42.9% | 125 | 0.0% | 0.00% | -25.0% |
| Q2 2015 | $7,000 | – | 125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 657,783 | $34,843,000 | 23.09% |
| Foresite Capital Management II, LLC | 344,770 | $18,262,000 | 6.41% |
| GROUP ONE TRADING, L.P. | 9,459 | $501,000 | 0.01% |
| STATE STREET CORP | 842,125 | $44,504,000 | 0.01% |
| Gemmer Asset Management LLC | 125 | $7,000 | 0.00% |